中国肺癌杂志
中國肺癌雜誌
중국폐암잡지
CHINESE JOURNAL OF LUNG CANCER
2009年
7期
735-740
,共6页
孙强玲%杨晓华%鲁静%谢银银%储天晴%沙慧芳
孫彊玲%楊曉華%魯靜%謝銀銀%儲天晴%沙慧芳
손강령%양효화%로정%사은은%저천청%사혜방
差异凝胶电泳%蛋白组学%分泌蛋白%紫杉醇%肺肿瘤
差異凝膠電泳%蛋白組學%分泌蛋白%紫杉醇%肺腫瘤
차이응효전영%단백조학%분비단백%자삼순%폐종류
Differential gel dectrophoresis%Proteomics%Secreted protein%Paclitaxol%Lung neoplasms
背景与目的 紫杉醇是用于肺癌临床一线治疗的作用于微管蛋白的化疗药物,而耐药是影响其疗效的关键因素.本研究应用蛋白组学技术整体比较紫杉醇耐药细胞与敏感细胞分泌蛋白表达谱,以期发现肺癌紫杉醇耐药相关分泌蛋白标志物,为临床选择有针对性的化疗药物提供依据.方法 收集A549亲代及耐药细胞培养液中的蛋白,应用差异凝胶电泳(DIGE)进行分离,Decyder 6.5软件分析后获得的差异蛋白点通过基质辅助激光解析电离飞行时间质谱(MALDI-TOF-MS)进行鉴定.结果 应用DIGE进行分离后,成功获得了蛋白质组分辨率高、重复性好的双向凝胶电泳图谱,Decyder 6.5软件分析获得差异>2倍以上的蛋白质点共有76个,经质谱鉴定了19种蛋白,鉴定的蛋白涉及代谢酶类、细胞外基质降解酶类、粘附分子、细胞因子和信号转导相关蛋白质.结论 本研究首次应用双向电泳技术整体展示了紫杉醇耐药细胞株及敏感细胞株的分泌蛋白表达谱,并分析、鉴定、筛选出与紫杉醇耐药相关的差异分泌蛋白.该研究为非小细胞肺癌血清耐药标志物的筛选提供了新的方法和候选分子.
揹景與目的 紫杉醇是用于肺癌臨床一線治療的作用于微管蛋白的化療藥物,而耐藥是影響其療效的關鍵因素.本研究應用蛋白組學技術整體比較紫杉醇耐藥細胞與敏感細胞分泌蛋白錶達譜,以期髮現肺癌紫杉醇耐藥相關分泌蛋白標誌物,為臨床選擇有針對性的化療藥物提供依據.方法 收集A549親代及耐藥細胞培養液中的蛋白,應用差異凝膠電泳(DIGE)進行分離,Decyder 6.5軟件分析後穫得的差異蛋白點通過基質輔助激光解析電離飛行時間質譜(MALDI-TOF-MS)進行鑒定.結果 應用DIGE進行分離後,成功穫得瞭蛋白質組分辨率高、重複性好的雙嚮凝膠電泳圖譜,Decyder 6.5軟件分析穫得差異>2倍以上的蛋白質點共有76箇,經質譜鑒定瞭19種蛋白,鑒定的蛋白涉及代謝酶類、細胞外基質降解酶類、粘附分子、細胞因子和信號轉導相關蛋白質.結論 本研究首次應用雙嚮電泳技術整體展示瞭紫杉醇耐藥細胞株及敏感細胞株的分泌蛋白錶達譜,併分析、鑒定、篩選齣與紫杉醇耐藥相關的差異分泌蛋白.該研究為非小細胞肺癌血清耐藥標誌物的篩選提供瞭新的方法和候選分子.
배경여목적 자삼순시용우폐암림상일선치료적작용우미관단백적화료약물,이내약시영향기료효적관건인소.본연구응용단백조학기술정체비교자삼순내약세포여민감세포분비단백표체보,이기발현폐암자삼순내약상관분비단백표지물,위림상선택유침대성적화료약물제공의거.방법 수집A549친대급내약세포배양액중적단백,응용차이응효전영(DIGE)진행분리,Decyder 6.5연건분석후획득적차이단백점통과기질보조격광해석전리비행시간질보(MALDI-TOF-MS)진행감정.결과 응용DIGE진행분리후,성공획득료단백질조분변솔고、중복성호적쌍향응효전영도보,Decyder 6.5연건분석획득차이>2배이상적단백질점공유76개,경질보감정료19충단백,감정적단백섭급대사매류、세포외기질강해매류、점부분자、세포인자화신호전도상관단백질.결론 본연구수차응용쌍향전영기술정체전시료자삼순내약세포주급민감세포주적분비단백표체보,병분석、감정、사선출여자삼순내약상관적차이분비단백.해연구위비소세포폐암혈청내약표지물적사선제공료신적방법화후선분자.
Background and objective Paclitaxol (PTX) resistance is one of main factors which affect the outcome of chemotherapy of lung adenocarcinoma. The aim of this study is to compare the secreted protein expression profiles between Paditaxol (PTX) resistant and sensitive lung adenocarcinoma cells by proteomic research method, so as to provide evidence of choosing individual chemotherapy drugs in clinical treatment. Methods Total secreted proteins extracted from a PTX sensitive cell line A549 and a PTX resistant cell line A549-Taxol were separated by fluorscent differential gel electrophoresis (DIGE). High quality 2-DE profiles were obtained and analyzed by Decyder 6.5 analysis software to screen differentially expressed protein spots. Those spots were identified by mass spectrometry. Results 2-DE patterns of lung adenocarcinoma cells with high-reso-lution and reproducibility were obtained. 76 significantly differentially expressed protein spots were screened, 19 proteins were identified by mass spectrometry. The identified proteins could be classified into different catogories: metabolic enzyme, extracel-lular matrix (ECM) degradation enzyme, cytokine, signal transducer, cell adhesion, and so on. Conclusion Multiple secreted proteins related to chemoresistance of A549-Taxol cells were identified in this study for the first time. The results presented here would provide dues to identify new serologic chemoresistant biomarkers of NSCLC.